Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime.
To prevent dissection injury when cutting strip preparations from human left ventricular papillary muscle tissue, dissections were carried out with 2,3-butanedione monoxime (30 mM) added to Krebs-Ringer solution and followed by washout with normal solution. Eleven muscle strip preparations were dissected from left ventricular papillary muscle tissue of five patients undergoing mitral valve replacement surgery. The average muscle strip length was 6.8 +/- 1.4 mm, and cross-section area was 0.49 +/- 0.16 mm2. Peak twitch tension was 2.02 +/- 1.33 g/mm2 and ranged from 0.67 to 5.5 g/mm2 at an extracellular calcium concentration of 2.5 mM (21 degrees C, 0.16 Hz). In one muscle strip, which was stored in Krebs-Ringer plus 2,3-butanedione monoxime solution for 20 hours, peak twitch tension in normal Krebs-Ringer solution was 1.85 g/mm2. When temperature was increased from 21 degrees C, there was a continuous increase in peak twitch tension (by 38%) up to about 28 degrees C; then peak twitch tension decreased so that at 37 degrees C (n = 3) average peak twitch tension was lower than at 21 degrees C by 47%. The force-frequency relation exhibited a broad force plateau between 40 and 120 beats/min at 37 degrees C. The plateau was markedly narrowed at 30 degrees C and 24 degrees C. Thermopile heat measurements revealed appropriate waveform characteristics in high-resolution single-beat heat records indicating minimal surface cell damage. Thus, cardioplegia with 2,3-butanedione monoxime protects human left ventricular myocardium from dissection injury facilitating dissection and preservation of strip preparations with extraordinarily low cross-sectional areas and high peak twitch tensions. These preparations are suitable for myothermal and mechanical measurements.
Mulieri
L A
LA
Department of Physiology and Biophysics, University of Vermont, College of Medicine, Burlington 05405.
Hasenfuss
G
G
Ittleman
F
F
Blanchard
E M
EM
Alpert
N R
NR
D000818:Animals; D002074:Butanones / Q000494:pharmacology*; D002801:Cholinesterase Reactivators / Q000494:pharmacology*; D003931:Diacetyl / Q000494:pharmacology* / Q000031:analogs & derivatives; D004210:Dissection / Q000009:adverse effects / Q000379:methods*; D004285:Dogs; D004558:Electric Stimulation; D006352:Heart Ventricles; D006801:Humans; D009200:Myocardial Contraction; D009206:Myocardium; D010210:Papillary Muscles / Q000503:physiopathology; D011817:Rabbits; D013048:Specimen Handling / Q000009:adverse effects / Q000379:methods*
D002074:Butanones; D002801:Cholinesterase Reactivators; C004717:diacetylmonoxime; D003931:Diacetyl